Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Endogenous testosterone and mortality in men: A systematic review and meta-analysis|
|Citation:||Journal of Clinical Endocrinology and Metabolism, 2011; 96(10):3007-3019|
|Andre B. Araujo, Julia M. Dixon, Elizabeth A. Suarez, M. Hassan Murad, Lin T. Guey, and Gary A. Wittert|
|Abstract:||<h4>Context</h4>Low testosterone levels have been associated with outcomes that reduce survival in men.<h4>Objective</h4>Our objective was to perform a systematic review and meta-analysis of published studies to evaluate the association between endogenous testosterone and mortality.<h4>Data sources</h4>Data sources included MEDLINE (1966 to December 2010), EMBASE (1988 to December 2010), and reference lists.<h4>Study selection</h4>Eligible studies were published English-language observational studies of men that reported the association between endogenous testosterone and all-cause or cardiovascular disease (CVD) mortality. A two-stage process was used for study selection. 1) Working independently and in duplicate, reviewers screened a subset (10%) of abstracts. Results indicated 96% agreement, and thereafter, abstract screening was conducted in singlicate. 2) All full-text publications were reviewed independently and in duplicate for eligibility.<h4>Data extraction</h4>Reviewers working independently and in duplicate determined methodological quality of studies and extracted descriptive, quality, and outcome data.<h4>Data synthesis</h4>Of 820 studies identified, 21 were included in the systematic review, and 12 were eligible for meta-analysis [n = 11 studies of all-cause mortality (16,184 subjects); n = 7 studies of CVD mortality (11,831 subjects)]. Subject mean age and testosterone level were 61 yr and 487 ng/dl, respectively, and mean follow-up time was 9.7 yr. Between-study heterogeneity was observed among studies of all-cause (P < .001) and CVD mortality (P = 0.06), limiting the ability to provide valid summary estimates. Heterogeneity in all-cause mortality (higher relative risks) was observed in studies that included older subjects (P = 0.020), reported lower testosterone levels (P = 0.018), followed subjects for a shorter time period (P = 0.010), and sampled blood throughout the day (P = 0.030).<h4>Conclusion</h4>Low endogenous testosterone levels are associated with increased risk of all-cause and CVD death in community-based studies of men, but considerable between-study heterogeneity, which was related to study and subject characteristics, suggests that effects are driven by differences between cohorts (e.g. in underlying health status).|
Body Mass Index
Cause of Death
Meta-Analysis as Topic
|Rights:||Copyright © 2011 by The Endocrine Society|
|Appears in Collections:||Aurora harvest|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.